PHI for adverse pathology and PHI density for upgrading: two complementary predictors in localized prostate cancer
Daniela Terracciano, Francesco Pellegrino, Mariano Fiorenza, Carmela Polito et autres
BACKGROUND: The Prostate Health Index (PHI) has emerged as a promising biomarker for improving prostate cancer (PCa) detection. However, its role in predicting pathological aggressiveness at radical prostatectomy (RP) requires further elucidation. We aimed to assess the ability of PHI and PHI …
it, us (code pays fourni par la source)
0 citations
Prostate Cancer and Prostatic Diseases